Cleared Traditional

K950670 - IMMULITE HERPES I AND II IGG

K950670 is the FDA 510(k) clearance for IMMULITE HERPES I AND II IGG by Diagnostic Products Corp.. It is a Class 2 Microbiology device (product code LGC) cleared through the Traditional 510(k) pathway after a 494-day FDA review.

K950670 · Diagnostic Products Corp. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1996
Decision
494d
Days
Class 2
Risk

K950670 is an FDA 510(k) clearance for the IMMULITE HERPES I AND II IGG. Classified as Enzyme Linked Immunoabsorbent Assay, Herpes Simplex Virus, Non-specific (product code LGC), Class II - Special Controls.

Submitted by Diagnostic Products Corp. (Los Angeles, US). The FDA issued a Cleared decision on June 21, 1996 after a review of 494 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3305 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Microbiology submissions.

View all Diagnostic Products Corp. devices

Submission Details

510(k) Number K950670 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 13, 1995
Decision Date June 21, 1996
Days to Decision 494 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
392d slower than avg
Panel avg: 102d · This submission: 494d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LGC Enzyme Linked Immunoabsorbent Assay, Herpes Simplex Virus, Non-specific
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3305
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LGC Enzyme Linked Immunoabsorbent Assay, Herpes Simplex Virus, Non-specific

All 26
Devices cleared under the same product code (LGC) and FDA review panel - the closest regulatory comparables to K950670.
HSV 1+2 IGG ELISA TEST
K983541 · Gull Laboratories, Inc. · Feb 1999
DIAMEDIX IS-HSV 1 & 2 IGG TEST SYSTEM
K981306 · Diamedix Corp. · Sep 1998
HERPES GROUP IGG ELISA TEST SYSTEM
K963645 · Armkel, LLC · Feb 1997
PREMIER HSV PLUS
K953839 · Meridian Diagnostics, Inc. · May 1996
ORTHO HSV ANTIGEN ELISA TEST, MODIFICATION
K925208 · Ortho Diagnostic Systems, Inc. · Dec 1992
BARTELS HERPES SIMPLEX VIRUS 2 IGM EIA
K922333 · Baxter Diagnostics, Inc. · Dec 1992